Literature DB >> 34978285

Culture and Imaging of Human Nasal Epithelial Organoids.

Zhongyu Liu1, Justin D Anderson1, Jennifer Natt1, Jennifer S Guimbellot2.   

Abstract

Individualized therapy for cystic fibrosis (CF) patients can be achieved with an in vitro disease model to understand baseline Cystic Fibrosis Transmembrane conductance Regulator (CFTR) activity and restoration from small molecule compounds. Our group recently focused on establishing a well-differentiated organoid model directly derived from primary human nasal epithelial cells (HNE). Histology of sectioned organoids, whole-mount immunofluorescent staining, and imaging (using confocal microscopy, immunofluorescent microscopy, and bright field) are essential to characterize organoids and confirm epithelial differentiation in preparation for functional assays. Furthermore, HNE organoids produce lumens of varying sizes that correlate with CFTR activity, distinguishing between CF and non-CF organoids. In this manuscript, the methodology for culturing HNE organoids are described in detail, focusing on the assessment of differentiation using the imaging modalities, including the measurement of baseline lumen area (a method of CFTR activity measurement in organoids that any laboratory with a microscope can employ) as well as the developed automated approach to a functional assay (which requires more specialized equipment).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34978285      PMCID: PMC9131700          DOI: 10.3791/63064

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.424


  38 in total

1.  Culturing of human nasal epithelial cells at the air liquid interface.

Authors:  Loretta Müller; Luisa E Brighton; Johnny L Carson; William A Fischer; Ilona Jaspers
Journal:  J Vis Exp       Date:  2013-10-08       Impact factor: 1.355

2.  A functional anatomic defect of the cystic fibrosis airway.

Authors:  Susan E Birket; Kengyeh K Chu; Linbo Liu; Grace H Houser; Bradford J Diephuis; Eric J Wilsterman; Gregory Dierksen; Marina Mazur; Suresh Shastry; Yao Li; John D Watson; Alexander T Smith; Benjamin S Schuster; Justin Hanes; William E Grizzle; Eric J Sorscher; Guillermo J Tearney; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2014-08-15       Impact factor: 21.405

3.  In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.

Authors:  Meghan E McGarry; Beate Illek; Ngoc P Ly; Lorna Zlock; Sabrina Olshansky; Courtney Moreno; Walter E Finkbeiner; Dennis W Nielson
Journal:  Pediatr Pulmonol       Date:  2017-01-09

4.  Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation.

Authors:  Venkateshwar Mutyam; Emily Falk Libby; Ning Peng; Denis Hadjiliadis; Michael Bonk; George M Solomon; Steven M Rowe
Journal:  J Cyst Fibros       Date:  2016-10-01       Impact factor: 5.482

5.  ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells.

Authors:  Xuefeng Liu; Virginie Ory; Sandra Chapman; Hang Yuan; Chris Albanese; Bhaskar Kallakury; Olga A Timofeeva; Caitlin Nealon; Aleksandra Dakic; Vera Simic; Bassem R Haddad; Johng S Rhim; Anatoly Dritschilo; Anna Riegel; Alison McBride; Richard Schlegel
Journal:  Am J Pathol       Date:  2011-12-18       Impact factor: 4.307

6.  Development of primary human nasal epithelial cell cultures for the study of cystic fibrosis pathophysiology.

Authors:  F de Courcey; A V Zholos; H Atherton-Watson; M T S Williams; P Canning; H L Danahay; J S Elborn; M Ennis
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-26       Impact factor: 4.249

7.  A functional CFTR assay using primary cystic fibrosis intestinal organoids.

Authors:  Johanna F Dekkers; Caroline L Wiegerinck; Hugo R de Jonge; Inez Bronsveld; Hettie M Janssens; Karin M de Winter-de Groot; Arianne M Brandsma; Nienke W M de Jong; Marcel J C Bijvelds; Bob J Scholte; Edward E S Nieuwenhuis; Stieneke van den Brink; Hans Clevers; Cornelis K van der Ent; Sabine Middendorp; Jeffrey M Beekman
Journal:  Nat Med       Date:  2013-06-02       Impact factor: 53.440

8.  Determinants of culture success in an airway epithelium sampling program of young children with cystic fibrosis.

Authors:  Luke W Garratt; Erika N Sutanto; Clara J Foo; Kak Ming Ling; Kevin Looi; Elizabeth Kicic-Starcevich; Thomas Iosifidis; Kelly M Martinovich; Francis J Lannigan; Stephen M Stick; Anthony Kicic
Journal:  Exp Lung Res       Date:  2014-09-05       Impact factor: 2.459

9.  Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies.

Authors:  John J Brewington; Erin T Filbrandt; F J LaRosa; Jessica D Moncivaiz; Alicia J Ostmann; Lauren M Strecker; John P Clancy
Journal:  JCI Insight       Date:  2018-07-12

10.  Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells.

Authors:  Paolo Scudieri; Ilaria Musante; Arianna Venturini; Daniela Guidone; Michele Genovese; Federico Cresta; Emanuela Caci; Alessandro Palleschi; Marco Poeta; Francesca Santamaria; Fabiana Ciciriello; Vincenzina Lucidi; Luis J V Galietta
Journal:  Cells       Date:  2020-09-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.